The company reported doubling revenues in 2011 and plans to use the new funds to support ongoing sales and marketing expansion, research and development for new product lines and building out of manufacturing infrastructure.
“This latest round of funding provides us with the resources to aggressively grow our business and invest in our scale up,” said CEO and chairman of the board Philipp Lang, MD, MBA. “It also provides us with the resources to pursue strategic initiatives in technology and intellectual property expansion.”
Related Articles on Orthopedic Devices:
NuVasive Shares Rise After Judge’s Ruling
Zimmer’s 2.9% Sales Increase Driven by Foreign Markets
Interventional Spine Receives FDA Clearance for Spine Device
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.